These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 23473947)
1. Synthesis, cyclooxygenase inhibitory effects, and molecular modeling study of 4-aryl-5-(4-(methylsulfonyl)phenyl)-2-alkylthio and -2-alkylsulfonyl-1H-imidazole derivatives. Assadieskandar A; Amirhamzeh A; Salehi M; Ozadali K; Ostad SN; Shafiee A; Amini M Bioorg Med Chem; 2013 Apr; 21(8):2355-2362. PubMed ID: 23473947 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological evaluation of substituted 2-alkylthio-1,5-diarylimidazoles as selective COX-2 inhibitors. Navidpour L; Shadnia H; Shafaroodi H; Amini M; Dehpour AR; Shafiee A Bioorg Med Chem; 2007 Mar; 15(5):1976-82. PubMed ID: 17258905 [TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-1 and cyclooxygenase-2 inhibition of novel 1,2-disubstituted imidazoles. Handler N; Jaeger W; Kuen-Krismer B; Erker T Arch Pharm (Weinheim); 2005 Dec; 338(12):602-4. PubMed ID: 16353278 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, cytotoxic evaluation and tubulin inhibitory activity of 4-aryl-5-(3,4,5-trimethoxyphenyl)-2-alkylthio-1H-imidazole derivatives. Assadieskandar A; Amini M; Ostad SN; Riazi GH; Cheraghi-Shavi T; Shafiei B; Shafiee A Bioorg Med Chem; 2013 May; 21(10):2703-9. PubMed ID: 23566762 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacological evaluation of 1H-imidazoles as ligands for the estrogen receptor and cytotoxic inhibitors of the cyclooxygenase. Wiglenda T; Ott I; Kircher B; Schumacher P; Schuster D; Langer T; Gust R J Med Chem; 2005 Oct; 48(20):6516-21. PubMed ID: 16190777 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of 2,3-diaryl-1,3-thiazolidine-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors. Zarghi A; Najafnia L; Daraee B; Dadrass OG; Hedayati M Bioorg Med Chem Lett; 2007 Oct; 17(20):5634-7. PubMed ID: 17822894 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of 6-substituted-3-(4-methanesulfonylphenyl)-4-phenylpyran-2-ones: a novel class of diarylheterocyclic selective cyclooxygenase-2 inhibitors. Praveen Rao PN; Amini M; Li H; Habeeb AG; Knaus EE J Med Chem; 2003 Nov; 46(23):4872-82. PubMed ID: 14584938 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and selective cyclooxygenase-2 (COX-2) inhibitory activity of a series of novel bicyclic pyrazoles. Ranatunge RR; Garvey DS; Janero DR; Letts LG; Martino AM; Murty MG; Richardson SK; Young DV; Zemetseva IS Bioorg Med Chem; 2004 Mar; 12(6):1357-66. PubMed ID: 15018908 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and cycloxygenase inhibitory properties of new naphthalene-methylsulfonamido, naphthalene-methylsulfonyl and tetrahydronaphthalen-methylsulfonamido compounds. Nencetti S; Ciccone L; Rossello A; Nuti E; Milanese C; Orlandini E J Enzyme Inhib Med Chem; 2015 Jun; 30(3):406-12. PubMed ID: 25089708 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization and preliminary screening of regioisomeric 1-(3-pyridazinyl)-3-arylpyrazole and 1-(3-pyridazinyl)-5-arylpyrazole derivatives towards cyclooxygenase inhibition. Unlü S; Banoglu E; Ito S; Niiya T; Eren G; Okçelik B; Sahin MF J Enzyme Inhib Med Chem; 2007 Jun; 22(3):351-61. PubMed ID: 17674817 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationship of novel, highly potent metharyl and methcycloalkyl cyclooxygenase-2 (COX-2) selective inhibitors. Khanapure SP; Garvey DS; Young DV; Ezawa M; Earl RA; Gaston RD; Fang X; Murty M; Martino A; Shumway M; Trocha M; Marek P; Tam SW; Janero DR; Letts LG J Med Chem; 2003 Dec; 46(25):5484-504. PubMed ID: 14640557 [TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of 2-substituted-1-naphthol derivatives on cyclooxygenase I and II. Kongkathip B; Sangma C; Kirtikara K; Luangkamin S; Hasitapan K; Jongkon N; Hannongbua S; Kongkathip N Bioorg Med Chem; 2005 Mar; 13(6):2167-75. PubMed ID: 15727869 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationship of a new series of COX-2 selective inhibitors: 1,5-diarylimidazoles. Almansa C; Alfón J; de Arriba AF; Cavalcanti FL; Escamilla I; Gómez LA; Miralles A; Soliva R; Bartrolí J; Carceller E; Merlos M; García-Rafanell J J Med Chem; 2003 Jul; 46(16):3463-75. PubMed ID: 12877584 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and cyclooxygenase inhibitory activities of some N-acylhydrazone derivatives of isoxazolo[4,5-d]pyridazin-4(5H)-ones. Unsal-Tan O; Ozden K; Rauk A; Balkan A Eur J Med Chem; 2010 Jun; 45(6):2345-52. PubMed ID: 20207453 [TBL] [Abstract][Full Text] [Related]
17. 3-(2-Methoxytetrahydrofuran-2-yl)pyrazoles: a novel class of potent, selective cyclooxygenase-2 (COX-2) inhibitors. Ranatunge RR; Earl RA; Garvey DS; Janero DR; Letts LG; Martino AM; Murty MG; Richardson SK; Schwalb DJ; Young DV; Zemtseva IS Bioorg Med Chem Lett; 2004 Dec; 14(24):6049-52. PubMed ID: 15546727 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and cyclooxygenase-2 inhibiting property of 1,5-diarylpyrazoles with substituted benzenesulfonamide moiety as pharmacophore: Preparation of sodium salt for injectable formulation. Pal M; Madan M; Padakanti S; Pattabiraman VR; Kalleda S; Vanguri A; Mullangi R; Mamidi NV; Casturi SR; Malde A; Gopalakrishnan B; Yeleswarapu KR J Med Chem; 2003 Sep; 46(19):3975-84. PubMed ID: 12954051 [TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, Docking Studies, Enzyme Inhibitory and Antiplatelet Aggregation Activities of New 1,3-Diphenyl-3-(Phenylthio)Propan-1-One Derivatives as Selective COX-2 Inhibitors. Bayanati M; Daraei B; Zarghi A Anticancer Agents Med Chem; 2023; 23(2):192-200. PubMed ID: 35692149 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of 1,3-diphenylprop-2-en-1-ones possessing a methanesulfonamido or an azido pharmacophore as cyclooxygenase-1/-2 inhibitors. Zarghi A; Zebardast T; Hakimion F; Shirazi FH; Rao PN; Knaus EE Bioorg Med Chem; 2006 Oct; 14(20):7044-50. PubMed ID: 16798002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]